Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) Shares Outstanding (Weighted Average) (2016 - 2025)

Dare Bioscience (DARE) has disclosed Shares Outstanding (Weighted Average) for 11 consecutive years, with $10.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Weighted Average) rose 17.17% year-over-year to $10.1 million, compared with a TTM value of $10.1 million through Sep 2025, up 17.17%, and an annual FY2024 reading of $8.5 million, up 16.8% over the prior year.
  • Shares Outstanding (Weighted Average) was $10.1 million for Q3 2025 at Dare Bioscience, up from $8.8 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $85.5 million in Q1 2023 and bottomed at $7.2 million in Q2 2023.
  • Average Shares Outstanding (Weighted Average) over 5 years is $38.5 million, with a median of $10.1 million recorded in 2025.
  • The sharpest move saw Shares Outstanding (Weighted Average) soared 124.06% in 2021, then plummeted 91.44% in 2023.
  • Year by year, Shares Outstanding (Weighted Average) stood at $61.2 million in 2021, then soared by 38.29% to $84.6 million in 2022, then crashed by 91.4% to $7.3 million in 2023, then rose by 16.8% to $8.5 million in 2024, then increased by 19.37% to $10.1 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for DARE at $10.1 million in Q3 2025, $8.8 million in Q2 2025, and $8.8 million in Q1 2025.